Get Live Data
Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. UK BROKER RATINGS SUMMARY: ODDO BHF Cuts IAG To Neutral From Buy

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,730.00
Bid: 1,733.00
Ask: 1,733.50
Change: -16.50 (-0.94%)
Spread: 0.50 (0.029%)
Open: 1,748.50
High: 1,752.50
Low: 1,730.00
Prev. Close: 1,746.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: ODDO BHF Cuts IAG To Neutral From Buy

Thu, 30th Apr 2020 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

ODDO BHF CUTS INTERNATIONAL CONSOLIDATED AIRLINES GROUP TO 'NEUTRAL' (BUY) - PRICE TARGET 2.80 (3.50) EUR

----------

LIBERUM CUTS RIGHTMOVE PRICE TARGET TO 470 (570) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS BT GROUP PRICE TARGET TO 110 (146) PENCE - 'SELL'

----------

DEUTSCHE BANK RAISES COMPASS GROUP PRICE TARGET TO 1506 (1200) PENCE - 'HOLD'

----------

HSBC CUTS SEGRO PRICE TARGET TO 833 (890) PENCE - 'HOLD'

----------

HSBC CUTS LAND SECURITIES PRICE TARGET TO 679 (897) PENCE - 'HOLD'

----------

JPMORGAN CUTS LAND SECURITIES PRICE TARGET TO 685 (775) PENCE - 'NEUTRAL'

----------

HSBC CUTS BRITISH LAND CO TO 'HOLD' ('BUY') - TARGET 385 (643) PENCE

----------

JPMORGAN CUTS BRITISH LAND CO PRICE TARGET TO 460 (490) PENCE - 'NEUTRAL'

----------

HSBC RAISES ASTRAZENECA PRICE TARGET TO 6690 (6450) PENCE - 'REDUCE'

----------

CREDIT SUISSE RAISES ASTRAZENECA PRICE TARGET TO 9000 (8500) PENCE - 'OUTPERFORM'

----------

BARCLAYS RAISES GLAXOSMITHKLINE PRICE TARGET TO 1550 (1450) PENCE - 'UNDERWEIGHT'

----------

GOLDMAN CUTS STANDARD CHARTERED PRICE TARGET TO 820 (850) PENCE - 'BUY'

----------

JPMORGAN CUTS RIO TINTO PRICE TARGET TO 4730 (4870) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES POLYMETAL PRICE TARGET TO 1800 (1500) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES GLENCORE PRICE TARGET TO 170 (140) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN CUTS FRESNILLO PRICE TARGET TO 550 (600) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES BHP PRICE TARGET TO 1830 (1820) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ANTOFAGASTA PRICE TARGET TO 700 (660) PENCE - 'UNDERWEIGHT'

----------

JPMORGAN RAISES ANGLO AMERICAN PRICE TARGET TO 2500 (2300) PENCE - 'OVERWEIGHT'

----------

CREDIT SUISSE CUTS INTERTEK PRICE TARGET TO 4400 (4550) PENCE - 'NEUTRAL'

----------

SHORE CAPITAL RESUMES J SAINSBURY WITH 'HOLD'

----------

SOCGEN CUTS NEXT TO 'SELL' ('HOLD') - TARGET 3522 (3998) PENCE

----------

JEFFERIES CUTS NEXT PRICE TARGET TO 5600 (6700) PENCE - 'HOLD'

----------

JPMORGAN RAISES WPP PRICE TARGET TO 750 (630) PENCE - 'OVERWEIGHT'

----------

FTSE 250

----------

JPMORGAN RAISES MITCHELLS & BUTLERS TO 'OVERWEIGHT' ('NEUTRAL') TARGET 340(490)P

----------

JPMORGAN CUTS MARSTONS PRICE TARGET TO 57 (128) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS JD WETHERSPOON PRICE TARGET TO 600 (1100) PENCE - 'UNDERWEIGHT'

----------

CITIGROUP CUTS TUI PRICE TARGET TO 125 (260) PENCE - 'SELL'

----------

PEEL HUNT CUTS GENUS TO 'HOLD' ('BUY')

----------

DEUTSCHE BANK RAISES IMI PRICE TARGET TO 1000 (940) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES SYNTHOMER PRICE TARGET TO 300 (265) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES SYNTHOMER PRICE TARGET TO 317 (274) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES ELEMENTIS PRICE TARGET TO 100 (75) PENCE - 'BUY'

----------

BERENBERG RAISES PLUS500 PRICE TARGET TO 1120 (1033) PENCE - 'HOLD'

----------

BARCLAYS CUTS WEIR GROUP PRICE TARGET TO 1200 (1750) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS KAZ MINERALS PRICE TARGET TO 400 (550) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES HOCHSCHILD MINING PRICE TARGET TO 170 (160) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS FERREXPO PRICE TARGET TO 130 (190) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS WORKSPACE PRICE TARGET TO 930 (980) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS GREAT PORTLAND PRICE TARGET TO 660 (825) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS DERWENT LONDON PRICE TARGET TO 2850 (3720) PENCE - 'UNDERWEIGHT'

----------

JEFFERIES RAISES IP GROUP TO 'BUY' ('HOLD') - TARGET 73 (72) PENCE

----------

INVESTEC RAISES KINGFISHER TO 'HOLD' ('SELL') - TARGET 160 (170) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

CITIGROUP RAISES RESTAURANT GROUP TO 'BUY' ('NEUTRAL')

----------

RBC CUTS HURRICANE ENERGY PRICE TARGET TO 30 (65) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS YOUNG & COS BREWERY PRICE TARGET TO 1230 (1550) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS PETRA DIAMONDS PRICE TARGET TO 5 (6) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS GEM DIAMONDS PRICE TARGET TO 40 (50) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS HELICAL PRICE TARGET TO 435 (475) PENCE - 'NEUTRAL'

----------

JEFFERIES CUTS DRAPER ESPRIT PRICE TARGET TO 487 (727) PENCE - 'BUY'

----------

JEFFERIES CUTS ALLIED MINDS PRICE TARGET TO 56 (99) PENCE - 'BUY'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more
20 Feb 2024 08:55

IN BRIEF: Diageo welcomes GSK's CFO as non-executive director

Diageo PLC - London-based brewer and distiller sells more than 200 drinks brands, including Guinness stout, Captain Morgan rum and Johnnie Walker whisky - Appoints GSK PLC's chief financial officer and executive director, Julie Brown, as a non-executive director. Says she will succeed Alan Stewart as chair of the audit committee after his retirement following the firm's annual general meeting in September. Chair Javier Ferran says: "Julie brings many years of experience in financial, commercial and strategic roles in international companies operating in highly regulated industries. She is strongly committed to enabling diversity in business and to creating sustainable, long-term value for stakeholders. I look forward to her contribution to Board discussions and to working with her in progressing Diageo's ambition to be one of the most trusted and respected consumer products companies in the world."

Read more
15 Feb 2024 14:44

UK dividends calendar - next 7 days

Friday 16 February 
JPMorgan Asia Growth & Income PLCdividend payment date
JPMorgan Japan Small Cap Growth & Income PLCdividend payment date
Murray International Trust PLCdividend payment date
Premier Miton Group PLCdividend payment date
Schroder Oriental Income Funddividend payment date
Solid State PLCdividend payment date
Monday 19 February 
no events scheduled 
Tuesday 20 February 
Invesco Bond Income Plus Ltd 
Wednesday 21 February 
no events scheduled 
Thursday 22 February 
abrdn Asia Focus PLCex-dividend payment date
Alumasc Group PLCex-dividend payment date
AstraZeneca PLCex-dividend payment date
BlackRock Throgmorton Trust PLCex-dividend payment date
Braemar PLCex-dividend payment date
easyJet PLCex-dividend payment date
Ecofin US Renewables Infrastructure Trust PLCex-dividend payment date
Endeavour Mining PLCex-dividend payment date
FRP Advisory Group PLCex-dividend payment date
Gateley Holdings PLCex-dividend payment date
GSK PLCex-dividend payment date
Hercules Site Services PLCex-dividend payment date
Jersey Electricity PLCex-dividend payment date
Land Securities Group PLCex-dividend payment date
Molten Ventures VCT PLCex-dividend payment date
Northern Bear PLCex-dividend payment date
Redrow PLCex-dividend payment date
Samuel Heath & Sons PLCex-dividend payment date
Titon Holdings PLCex-dividend payment date
Unilever PLCex-dividend payment date
Van Elle Holdings PLCex-dividend payment date
Virgin Money UK PLCex-dividend payment date
Witan Investment Trust PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
15 Feb 2024 11:02

Berenberg hikes target price on GSK

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker GSK from £16.50 to £18.20 on Thursday, stating the group was moving closer to offsetting losses associated with the expiry of its patent on HIV drug dolutegravir.

Read more
15 Feb 2024 09:45

LONDON BROKER RATINGS: Jefferies cuts Kingfisher but Citi raises

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
15 Feb 2024 08:49

GSK completes USD1.4 billion purchase of respiratory firm Aiolos Bio

(Alliance News) - GSK PLC on Thursday said it has completed the acquisition of Aiolos Bio Ltd, expanding its respiratory portfolio with a potential "best-in-class" asthma treatment.

Read more
13 Feb 2024 16:53

LONDON MARKET CLOSE: Stocks in red amid sticky US inflation data

(Alliance News) - Stock prices in London closed in the red on Tuesday, after a key US inflation reading came in hotter-than-expected.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 16:21

London close: Stocks fall as US inflation tops expectations

(Sharecast News) - London markets ended the trading day in negative territory on Tuesday, influenced by concerns over higher inflation figures from the United States and a deceleration in wage growth within the UK.

Read more
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:45

Citi ups recommendation on GSK to 'buy'

(Sharecast News) - Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates.

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.